Baseline assessment of pharmacovigilance activities in four sub-Saharan African countries: a perspective on tuberculosis

BACKGROUND: New medicines have become available for the treatment of drug-resistant tuberculosis (DR-TB) and are introduced in sub-Saharan Africa (SSA) by the national TB programs (NTPs) through special access schemes. Pharmacovigilance is typically the task of national medicines regulatory agencies...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiemersma, Everdina W., Ali, Ibrahim, Alemu, Asnakech, Avong, Yohanna Kambai, Duga, Alemayehu, Elagbaje, Cassandra, Isah, Ambrose, Kay, Alexander, Mmbaga, Blandina Theophil, Mmari, Elice, Mwamwitwa, Kissa, Nhlabatsi, Siphesihle, Sintayehu, Kassech, Arefayne, Aida, Teferi, Mekonnen, Cobelens, Frank, Härmark, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499544/
https://www.ncbi.nlm.nih.gov/pubmed/34625085
http://dx.doi.org/10.1186/s12913-021-07043-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499544/
https://www.ncbi.nlm.nih.gov/pubmed/34625085
http://dx.doi.org/10.1186/s12913-021-07043-6

Ejemplares similares